Success Metrics

Clinical Success Rate

50.0%

Based on 1 completed trials

Completion Rate

50%(1/2)

Active Trials

0(0%)

Results Posted

0%(0 trials)

Terminated

1(33%)

Phase Distribution

Ph phase_1

33%

Ph phase_4

33%

Ph not_applicable

33%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution3 total trials

Phase 1Safety & dosage

1(33.3%)

Phase 4Post-market surveillance

1(33.3%)

N/ANon-phased studies

1(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

33.3%

1 of 3 finished

Non-Completion Rate

66.7%

2 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(1)

Terminated(2)

Detailed Status

Terminated1

Completed1

Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

50.0%

Most Advanced

Phase 4

Trials by Phase

Phase 11 (33.3%)

Phase 41 (33.3%)

N/A1 (33.3%)

Trials by Status

terminated133%

completed133%

withdrawn133%

Recent Activity

0 active trials

Showing 3 of 3

terminatedphase_4

Treatment With Continuous Sub-cutaneous Insulin Infusion Via a Portable Pump Versus Discontinuous Insulin Infusion Via Multiple-injections in Type 2 Diabetes

NCT02048189

completedphase_1

A Randomised, Single Centre, Double-Blind, Two-Period Crossover, Glucose Clamp Trial

NCT00810589

withdrawnnot_applicable

Sub-Cutaneous Insulin in Hyperglycaemic Emergencies

NCT00467246

Clinical Trials (3)

Showing 3 of 3 trials

NCT02048189Phase 4

Treatment With Continuous Sub-cutaneous Insulin Infusion Via a Portable Pump Versus Discontinuous Insulin Infusion Via Multiple-injections in Type 2 Diabetes

Terminated

NCT00810589Phase 1

A Randomised, Single Centre, Double-Blind, Two-Period Crossover, Glucose Clamp Trial

Completed

NCT00467246Not Applicable

Sub-Cutaneous Insulin in Hyperglycaemic Emergencies

Withdrawn

All 3 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 3